Genotyping of high-risk human papilloma virus (HR-HPV) and its role in cervical cancer among suspected women at reproductive age

Moneira A. Mansour; Mogahid M. Elhassan; Faris M. Eltom; Hala M. Yousif; Hashim M. Missawi; Eshraga O. Mohamed; Ibrahim B. Elemam; Bahjat S. Farsi

doi:10.5897/AJMR2017.8763

African Journal of
Microbiology Research

Abbreviation: Afr. J. Microbiol. Res.
Language: English
ISSN: 1996-0808
DOI: 10.5897/AJMR
Start Year: 2007
Published Articles: 5211

Full Length Research Paper

Genotyping of high-risk human papilloma virus (HR-HPV) and its role in cervical cancer among suspected women at reproductive age

Moneira A. Mansour

Moneira A. Mansour
Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
Search for this author on:
Google Scholar

Mogahid M. Elhassan

Mogahid M. Elhassan
Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
Search for this author on:
Google Scholar

Faris M. Eltom

Faris M. Eltom
Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, Taibah University, Al-Madinah Al Munawarah, KSA.
Search for this author on:
Google Scholar

Hala M. Yousif

Hala M. Yousif
Department of Pathology, College of Medicine, Taibah University, Al-Madinaah Al-Munawarah, KSA.
Search for this author on:
Google Scholar

Hashim M. Missawi

Hashim M. Missawi
Department of Clinical Pathology, Maternity and Children Hospital Ministry of Health, Al-Madinah Al Munawarah, KSA.
Search for this author on:
Google Scholar

Eshraga O. Mohamed

Eshraga O. Mohamed
Department of Microbiology, College of Medical Laboratory Science, Shandi University, Shandi, Sudan.
Search for this author on:
Google Scholar

Ibrahim B. Elemam

Ibrahim B. Elemam
Department of Microbiology, College of Medical Laboratory Science, Shandi University, Shandi, Sudan.
Search for this author on:
Google Scholar

Bahjat S. Farsi

Bahjat S. Farsi
Department of Clinical Pathology, Maternity and Children Hospital Ministry of Health, Al-Madinah Al Munawarah, KSA.
Search for this author on:
Google Scholar

Article Number - 633317755615
Vol.11(48), pp. 1693-1698 , December 2017
https://doi.org/10.5897/AJMR2017.8763

Received: 04 November 2017
Accepted: 14 December 2017
Published: 28 December 2017

References

Al-Badawi IA, Al-Suwaine A, Al-Aker M, Asaad L, Alaidan A, Tulbah A, Fe Bohol M, Munkarah AR (2011). Detection and genotyping of human papilloma virus in cervical cancer specimens from Saudi patients. Int. J. Gynecol. Cancer 21:907-910. Crossref

Alsbeih G, Ahmed R, Al-Harbi N, Venturina LA, Tulbah A, Balaraj K (2011). Prevalence and genotypes' distribution of human papillomavirus in invasive cervical cancer in Saudi Arabia. Gynecol. Oncol. 121:522-526. Crossref

Altaf FJ (2008). Cervical cancer screening with pattern of pap smear. Rev. Multicent. Stud. 27(10):1498-502.

Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202:1789-1799. Crossref

Darnel AD, Wang D, Ghabreau L, Yasmeen A, Sami S, Akil N, Al Moustafa AE (2010). Correlation between the presence of highâ€risk human papillomaviruses and Id gene expression in Syrian women with cervical cancer. Clin. Microbiol. Infect. 16(3):262-266. Crossref

de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol. 11(11):1048-5610. Crossref

Enerly E, Bonde J, Schee K, Pedersen H, Lonnberg S, Nygard M (2016). Self-sampling for human Papillomavirus testing among non-attenders increases attendance to the Norwegian cervical cancer screening programme. PLoS One 11(4): e0151978. Crossref

Farnsworth A (2011). Screening for the prevention of cervical cancer in the era of human papillomavirus vaccination: An Australian perspective. Acta Cyto. 55:307-312. Crossref

Ghazi A (2014). HPV Infection in Cervical and Other Cancers in Saudi Arabia. Implication for Prevention and Vaccination. Oncol. 4:65.

Ghazi A, Najla A, Medhat E, Ismail A (2013). HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infec. Agen. Can. 20138:15.

Hammouda D, Clifford GM, Pallardy S, Ayyach G, Chekiri A, Boudrich A, Snijders PJ, van Kemenade FJ, Meijer CJ, Bouhadef A (2011). Human papillomavirus infection in a population-based sample of women in Algiers, Algeria. Int. J. Cancer. 128:2224-2229. Crossref

Hussain S, Bharadwaj M, Nasare V, Kumari M, Sharma S, Hedau S, Das BC (2012). Human papillomavirus infection among young adolescents in India: impact of vaccination. J. Med. Virol.84:298-305. Crossref

ICO Information Centre on HPV and Cancer (2010). Human Papillomavirus and Related Cancers Infection. ICO HPV Information Centre, Institut Català d'Oncologia, Avda. Gran Via de l'Hospitalet, 199-203, 08908 L'Hospitalet de Llobregat (Barcelona, Spain) 16(3):262-6.

Khorasanizadeh F, Hassanloo J, Khaksar N, Taheri SM, Marzaban M, Rashidi BH, Sari AA, Zendehdel K (2012). Epidemiology of cervical cancer and human papilloma virus infection among Iranian women-Analyses of national data and systematic review of the literature. Gynecol. Oncol. 128:277-281. Crossref

Koshiol J, Lindsay L, Pimenta JM, Poole C, Jenkins D (2000). Persistent human papillomavirus infection and cervical neoplasia: A systematic review and meta-analysis. Am. J. Epidemiol. 168:123-137. Crossref

Lam JUH, Elfstro KM, Ejegod DM, Pedersen H, Rygaard C, Rebolj M, Lynge E, Juul KE, Kjær SK, Dillner J, Bonde J (2018). High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders British Journal of Cancer 118:138-144. Crossref

Lowy DR, Schiller JT (2015). Reducing HPV-associated cancer globally. Cancer Prev. Res. (Philadelphia) 5(1):18-23. Crossref

Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR, Kyrgiou M. (2016). The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome Microbiome. 14(1):58. Crossref

McLaughlin-Drubin M, Munger K (2008). Viruses associated with human cancer. Biochim Biophys Acta. 1782:127-50. Crossref

Ostor AG (1993). The natural history of cervical intra epithelial neoplasia of the uterine cervix. Int. Gynecol. Pathol. 12:186-92. Crossref

Parkin D (2002). The global health burden of infection associated cancers in the year. Int. J. Cancer. 118:3030-3044. Crossref

Poljak M, Kovanda A, Kocjan BJ, Seme K, Jancar N, Vrtacnik-Bokal E (2009). The Abbott RealTime High Risk HPV test: Comparative evaluation of analytical specificity and clinical sensitivity for cervical carcinoma and CIN 3 lesions with the Hybrid Capture 2 HPV DNA test. Acta Dermatovenerol. Alp. Panon. Adriat. 18:94-103.

Sambrook J, Russell D, Gola J (2001). Molecular cloning, third ed, A laboratory manual. 1:32-34.

Sankaranarayan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA (2009). HPV screening for cervical cancer in Rural India. N. Engl. J. Med. 360:1385-1394. Crossref

Sawaya GF, Kerlikowske K, Lee NC,Gildengorin G, Washington AE (2000). Frequency of cervical smear abnormalities within 3 years of normal cytology. Obstet. Gynecol. 96(2):219-23.

Saudi Cancer Report (SCR) (2011). Cancer Incidence and Survival Report: Saudi Arabia 2007. Special Edition. Saudi Cancer Registry 2011; Riyadh, Kingdom of Saudi Arabia: Ministry of Health. Available at: View

Sin HL, Vigliotti JS, Vigliotti VS, Jones W (2014). From human papillomavirus (HPV) detection to cervical cancer prevention in clinical practice. Cancers. 6(4):2072-2099. Crossref

Stanley MA (2009). Immune responses to human papilloma viruses. Indian J. Med. Res. 130:266-276.

Sultana F, English DR, Simpson JA, Drennan KT, Mullins R, Brotherton JM, Wrede CD, Heley S, Saville M, Gertig DM (2016) Home-based HPV self-sampling improves participation by never-screened and under-screened women: Results from a large randomized trial (iPap) in Australia. Int J Cancer 139(2):281-290. Crossref

Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'leary J, Joura EA, Rosenlund M, Colau B (2013). Differences in human papillomavirus type distribution in highâ€grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int. J. Cancer. 132(4):854-867. Crossref

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189(1):12-19. Crossref

PubMedWHO/ICO (2012). Information center on human papilloma virus (HPV) and cervical cancer 2011. View [(accessed on 2 May 2014)]. 84: 298-305.